Prof. Cimi Ilmiawati, MD, PhD is a faculty member of the Department of Pharmacology and Therapeutics, Faculty of Medicine, Universitas Andalas, Indonesia, where she has served since 2008. She currently holds the position of Head of the Master’s Program in Biomedical Sciences at the same faculty. She obtained her medical degree from Universitas Andalas in 2006 and completed her Ph.D. in Environmental Health and Preventive Medicine at Jichi Medical University, Japan, in 2014. Dr. Ilmiawati has undertaken postdoctoral research in Japan supported by the Takeda Science Foundation (2016) and in the United States as a Fulbright Visiting Scholar (2021). Dr. Ilmiawati teaches at undergraduate, master’s, and doctoral levels in medicine, biomedical sciences, and public health. Her expertise lies in environmental toxicology, with molecular biology and epidemiological approaches. Her research has been published in reputable international and national journals and presented at numerous scientific conferences. Currently, her work focuses on potentially toxic compounds in cosmetics and their health impacts on women of reproductive age.

Hongkang Wu completed a Bachelor of Biomedicine (Degree with Honours) at the University of Melbourne in 2021, conducting his Honours research at The Florey. He continued his graduate studies within the same group under the supervision of Professor Akhter Hossain, Professor Ross Bathgate, Professor John Furness, and Dr Ruslan Pustovit. His doctoral research focuses on developing next-generation therapeutics based on the insulin/relaxin superfamily of peptides, with particular emphasis on simplified insulin-like peptide 5 (INSL5) analogues as colon motility regulators. By integrating solid-phase peptide synthesis, medicinal chemistry, receptor pharmacology, and structure-activity relationship studies, he designs drug-like analogues with enhanced potency and selectivity to modulate relaxin family peptide receptors (RXFPs). Hongkang has published first-author papers in high-impact journals such as the Journal of Medicinal Chemistry. He is passionate about bridging the gap between discovery and application in peptide science and welcomes interdisciplinary collaborations in peptide drug design, GPCR biology, and therapeutic innovation.

Dr. Zhao earned her Ph.D. in Pharmacology from Lund University, Sweden, and has authored over 100 publications on gastrointestinal pharmacology. She is recognized for her groundbreaking discovery that denervation suppresses gastric tumorigenesis (doi:10.1126/scitranslmed.3009569), a landmark finding that helped establish the emerging field of Cancer Neuroscience. She has held top-level researcher and professor positions at NTNU and is a lifetime member of the Royal Norwegian Society of Sciences and Letters (Det Kongelige Norske Videnskabers Selskab, DKNVS).

Vladimir Matchkov is a Professor of Cardiovascular Physiology at Aarhus University, Denmark, where he leads the Neurovascular Coupling Group. He received his PhD from Lomonosov Moscow State University in 1998 and his DMSc from Aarhus University in 2010. His research focuses on cardiovascular function and membrane ion transport, with 124 peer-reviewed publications. He organized and for several years led the Vascular Special Interest Group and currently serves as Secretary-General of the Scandinavian Physiological Society. He also leads the Phenotyping Core Facility at the Department of Biomedicine, with a primary focus on cardiovascular and metabolic disturbances in rodent models. Prof. Matchkov is an active and dedicated teacher of medical physiology.

A lecturer in Pharmacology with 12 years of practical experience in intellectual property (IP) law practice through my position as a senior pharmaceutical patent examiner in the Egyptian Patent Office. I’ve got my Ph.D. & Master's in Pharmacology and Toxicology as well as my bachelor's from the Faculty of Pharmacy Cairo University & my Master's in IP Law from Turin University. She established the first IP curriculum for pharmacy students in Egypt among the postgrad programmes. She drafted the IP policy of The British University in Egypt through my role as an IP consultant at the BUE. I delivered several international training programs in many countries, Korea; Kuwait; Tunisia; Arab States of Emirates, in addition to Egypt. She is a certified trainer for IP in the World Intellectual Property Organisation (WIPO) for Arabic- & English-speaking countries; and a certified IP expert from the League of Arab States, as well as a certified trainer in Van Holland University for soft skills and human development programs. She participated in many online courses as a tutor for the European Patent Academy, National IP Academy of Egypt, and as a tutor for delivering the “Patent Drafting Course” on the WIPO Academy platform. She graduated from the copyright program, “CopyrightX” and am a student in the “PatentX program” at Harvard University. I’ve several research papers in the pharmaceutical as well as the IP field and I participated in several national & international pharmaceutical conferences with posters or oral talks about IP and pharmaceutical sciences.

Dr. Chandragouda R. Patil is an accomplished academician and researcher with over 27 years of experience in pharmacology. He is a recipient of the prestigious National Award for Teachers conferred by the President of India and the Innovator Teacher Award by MHRD, where he ranked among the top seven professors nationwide. Selected among the top 200 academicians for LEAP-2020 under the PMMMNMTT initiative, he uniquely represented the Indian pharmacy fraternity. Dr. Patil has organized AICTE-sponsored faculty development programs and delivered expert lectures at over 85 institutions, including Institute of Chemical Technology Mumbai. His research excellence is marked by over 120 publications, three Indian patents, and significant grant funding exceeding ₹5 crore. He has received the Young Scientist Award and developed innovative virtual pharmacology tools, earning international recognition for promoting alternatives to animal experimentation.